Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
18.18
+0.07 (0.39%)
At close: Oct 17, 2025, 4:00 PM EDT
18.54
+0.36 (1.98%)
After-hours: Oct 17, 2025, 7:17 PM EDT

Cellebrite DI Statistics

Total Valuation

Cellebrite DI has a market cap or net worth of $4.44 billion. The enterprise value is $3.91 billion.

Market Cap4.44B
Enterprise Value 3.91B

Important Dates

The next confirmed earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date Nov 12, 2025
Ex-Dividend Date n/a

Share Statistics

Cellebrite DI has 244.47 million shares outstanding. The number of shares has increased by 17.65% in one year.

Current Share Class 244.47M
Shares Outstanding 244.47M
Shares Change (YoY) +17.65%
Shares Change (QoQ) -0.13%
Owned by Insiders (%) 2.65%
Owned by Institutions (%) 39.60%
Float 112.43M

Valuation Ratios

PE Ratio n/a
Forward PE 35.82
PS Ratio 9.57
Forward PS 8.55
PB Ratio 10.88
P/TBV Ratio 12.03
P/FCF Ratio 29.60
P/OCF Ratio 27.59
PEG Ratio 2.34
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.45, with an EV/FCF ratio of 26.04.

EV / Earnings n/a
EV / Sales 8.95
EV / EBITDA 52.45
EV / EBIT 61.12
EV / FCF 26.04

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.05.

Current Ratio 1.96
Quick Ratio 1.82
Debt / Equity 0.05
Debt / EBITDA 0.28
Debt / FCF 0.15
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -81.98% and return on invested capital (ROIC) is 19.87%.

Return on Equity (ROE) -81.98%
Return on Assets (ROA) 5.95%
Return on Invested Capital (ROIC) 19.87%
Return on Capital Employed (ROCE) 13.40%
Revenue Per Employee $374,235
Profits Per Employee -$129,347
Employee Count1,167
Asset Turnover 0.65
Inventory Turnover 7.45

Taxes

In the past 12 months, Cellebrite DI has paid $6.43 million in taxes.

Income Tax 6.43M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +0.11% in the last 52 weeks. The beta is 1.29, so Cellebrite DI's price volatility has been higher than the market average.

Beta (5Y) 1.29
52-Week Price Change +0.11%
50-Day Moving Average 17.18
200-Day Moving Average 18.20
Relative Strength Index (RSI) 49.12
Average Volume (20 Days) 1,409,844

Short Selling Information

The latest short interest is 7.43 million, so 3.04% of the outstanding shares have been sold short.

Short Interest 7.43M
Short Previous Month 8.02M
Short % of Shares Out 3.04%
Short % of Float 6.61%
Short Ratio (days to cover) 3.97

Income Statement

In the last 12 months, Cellebrite DI had revenue of $436.73 million and -$150.95 million in losses. Loss per share was -$0.66.

Revenue436.73M
Gross Profit 368.50M
Operating Income 63.96M
Pretax Income -144.52M
Net Income -150.95M
EBITDA 74.53M
EBIT 63.96M
Loss Per Share -$0.66
Full Income Statement

Balance Sheet

The company has $472.18 million in cash and $22.33 million in debt, giving a net cash position of $535.51 million or $2.19 per share.

Cash & Cash Equivalents 472.18M
Total Debt 22.33M
Net Cash 535.51M
Net Cash Per Share $2.19
Equity (Book Value) 408.41M
Book Value Per Share 1.67
Working Capital 296.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $161.08 million and capital expenditures -$10.95 million, giving a free cash flow of $150.13 million.

Operating Cash Flow 161.08M
Capital Expenditures -10.95M
Free Cash Flow 150.13M
FCF Per Share $0.61
Full Cash Flow Statement

Margins

Gross margin is 84.38%, with operating and profit margins of 14.64% and -34.56%.

Gross Margin 84.38%
Operating Margin 14.64%
Pretax Margin -33.09%
Profit Margin -34.56%
EBITDA Margin 17.07%
EBIT Margin 14.64%
FCF Margin 34.38%

Dividends & Yields

Cellebrite DI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.65%
Shareholder Yield -17.65%
Earnings Yield -3.40%
FCF Yield 3.38%
Dividend Details

Analyst Forecast

The average price target for Cellebrite DI is $22.60, which is 24.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target $22.60
Price Target Difference 24.31%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 15.62%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Cellebrite DI has an Altman Z-Score of 7.45 and a Piotroski F-Score of 5.

Altman Z-Score 7.45
Piotroski F-Score 5